Radiotherapy for Advanced Hodgkin Lymphoma with Initial Bulk: A Combined Analysis of Two Randomized Trials
CONCLUSIONS: In this combined analysis of 2 randomized phase 3 clinical trials, consolidative RT to initial sites of bulky nodal involvement was not associated with a PFS benefit in patients with advanced Hodgkin lymphoma in metabolic complete response after 2 and 6 cycles of doxorubicin, bleomycin, vinblastine and dacarbazine.PMID:38550369 | PMC:PMC10965437 | DOI:10.1016/j.adro.2024.101450
Source: Adv Data - Category: Epidemiology Authors: Ryan T Hughes Niema B Razavian Rachel F Shenker Christopher R Kelsey Sydney Smith Ralph B D'Agostino Karen M Winkfield Source Type: research
More News: Clinical Trials | Epidemiology | Hodgkin's Disease | Lymphoma | Radiation Therapy | Statistics